498 related articles for article (PubMed ID: 33928374)
1. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
Bernal E; Gimeno L; Alcaraz MJ; Quadeer AA; Moreno M; Martínez-Sánchez MV; Campillo JA; Gomez JM; Pelaez A; García E; Herranz M; Hernández-Olivo M; Martínez-Alfaro E; Alcaraz A; Muñoz Á; Cano A; McKay MR; Muro M; Minguela A
J Infect Dis; 2021 Jul; 224(2):229-240. PubMed ID: 33928374
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
3. A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity.
Beksac M; Akin HY; Gencer-Oncul EB; Yousefzadeh M; Cengiz Seval G; Gulten E; Akdemir Kalkan I; Cinar G; Memikoglu O; Karaagaoglu E; Dalva K
Immunogenetics; 2021 Dec; 73(6):449-458. PubMed ID: 34536086
[TBL] [Abstract][Full Text] [Related]
4. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.
Jackson E; Zhang CX; Kiani Z; Lisovsky I; Tallon B; Del Corpo A; Gilbert L; Bruneau J; Thomas R; Côté P; Trottier B; LeBlanc R; Rouleau D; Tremblay C; Tsoukas CM; Routy JP; Ni X; Mabanga T; Bernard NF;
PLoS One; 2017; 12(9):e0185160. PubMed ID: 28938026
[TBL] [Abstract][Full Text] [Related]
5. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid.
Balas A; Moreno-Hidalgo MÁ; de la Calle-Prieto F; Vicario JL; Arsuaga M; Trigo E; de Miguel-Buckley R; Bellón T; Díaz-Menéndez M
Hum Immunol; 2023 Nov; 84(11):571-577. PubMed ID: 37777360
[TBL] [Abstract][Full Text] [Related]
7. Association of KIR gene polymorphisms with COVID-19 disease.
Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
Clin Immunol; 2022 Jan; 234():108911. PubMed ID: 34929414
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
9. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Misra MK; Prakash S; Moulik NR; Kumar A; Agrawal S
Hum Immunol; 2016 Jan; 77(1):41-46. PubMed ID: 26472014
[TBL] [Abstract][Full Text] [Related]
10. Killer-cell immunoglobulin-like receptors associated with polycystic ovary syndrome.
Sala Elpidio LN; de Alencar JB; Tsuneto PY; Alves HV; Trento Toretta M; It Taura SK; Laguila Visentainer JE; Sell AM
J Reprod Immunol; 2018 Nov; 130():1-6. PubMed ID: 30099219
[TBL] [Abstract][Full Text] [Related]
11. The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province.
Kakodkar P; Dokouhaki P; Wu F; Shavadia J; Nair R; Webster D; Sawyer T; Huan T; Mostafa A
Hum Immunol; 2023 Mar; 84(3):163-171. PubMed ID: 36707385
[TBL] [Abstract][Full Text] [Related]
12. HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
Farias TDJ; Brugiapaglia S; Croci S; Magistroni P; Curcio C; Zguro K; Fallerini C; Fava F; Pettini F; Kichula KM; Pollock NR; Font-Porterias N; Palmer WH; Marin WM; Baldassarri M; Bruttini M; Hollenbach JA; Hendricks AE; Meloni I; Novelli F; ; Renieri A; Furini S; Norman PJ; Amoroso A
HLA; 2024 Jan; 103(1):e15251. PubMed ID: 37850268
[TBL] [Abstract][Full Text] [Related]
13. Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study.
Goedert JJ; Martin MP; Vitale F; Lauria C; Whitby D; Qi Y; Gao X; Carrington M
J Infect Dis; 2016 Feb; 213(3):432-8. PubMed ID: 26268853
[TBL] [Abstract][Full Text] [Related]
14. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
[TBL] [Abstract][Full Text] [Related]
15. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Casuccio A; Di Bona D; Aiello A; Accardi G; Arnao V; Clemente G; Corte VD; Maida C; Simonetta I; Caruso C; Squatrito R; Pinto A;
J Neuroinflammation; 2019 Apr; 16(1):88. PubMed ID: 30995924
[TBL] [Abstract][Full Text] [Related]
16. Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance.
Guillamón CF; Martínez-Sánchez MV; Gimeno L; Campillo JA; Server-Pastor G; Martínez-García J; Martínez-Escribano J; Torroba A; Ferri B; Abellán DJ; Legaz I; López-Álvarez MR; Moya-Quiles MR; Muro M; Minguela A
Cancer Immunol Res; 2019 Aug; 7(8):1307-1317. PubMed ID: 31239317
[TBL] [Abstract][Full Text] [Related]
17. Reduced frequency of two activating KIR genes in patients with sepsis.
Oliveira LM; Portela P; Merzoni J; Lindenau JD; Dias FS; Beppler J; Graebin P; Alho CS; Schwartsmann G; Dal-Pizzol F; Jobim LF; Jobim M; Roesler R
Hum Immunol; 2017 Apr; 78(4):363-369. PubMed ID: 28213050
[TBL] [Abstract][Full Text] [Related]
18. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study.
Pan N; Jiang W; Sun H; Miao F; Qiu J; Jin H; Xu J; Shi Q; Xie W; Zhang J
PLoS One; 2011; 6(10):e25682. PubMed ID: 21998681
[TBL] [Abstract][Full Text] [Related]
19. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
Varbanova V; Naumova E; Mihaylova A
Cancer Immunol Immunother; 2016 Apr; 65(4):427-40. PubMed ID: 26874942
[TBL] [Abstract][Full Text] [Related]
20. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
